$ACAN
AmeriCann, Inc.

2023 Q4 Form 10-K Financial Statement

#000143774923035268 Filed on December 22, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023
Revenue $475.6K $486.2K $2.552M
YoY Change -35.27% -40.11% -12.83%
Cost Of Revenue $780.00 $2.560K $16.17K
YoY Change -94.27% -78.67% -64.81%
Gross Profit $474.8K $483.6K $2.536M
YoY Change -34.15% -39.53% -12.0%
Gross Profit Margin 99.84% 99.47% 99.37%
Selling, General & Admin $515.7K $477.7K $1.924M
YoY Change 0.49% 3.85% -19.79%
% of Gross Profit 108.61% 98.77% 75.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $115.6K $115.9K $455.9K
YoY Change 2.74% 3.03% 1.33%
% of Gross Profit 24.34% 23.96% 17.98%
Operating Expenses $515.7K $477.7K $1.924M
YoY Change 0.49% 3.85% -19.79%
Operating Profit -$40.89K $5.940K $611.7K
YoY Change -119.67% -98.25% 26.71%
Interest Expense -$131.1K -$154.1K -$706.4K
YoY Change -29.19% -7.71% 7.69%
% of Operating Profit -2594.78% -115.49%
Other Income/Expense, Net -$131.1K -$706.4K
YoY Change -29.2% 7.69%
Pretax Income -$172.0K -$148.2K -$94.76K
YoY Change -856.04% -185.76% -45.3%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$172.0K -$148.2K -$94.76K
YoY Change -856.21% -185.76% -45.31%
Net Earnings / Revenue -36.16% -30.48% -3.71%
Basic Earnings Per Share -$0.01 $0.00
Diluted Earnings Per Share -$0.01 -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 24.39M 24.39M 24.39M
Diluted Shares Outstanding 24.39M 24.39M

Balance Sheet

Concept 2023 Q4 2023 Q3 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $807.6K $1.135M $1.135M
YoY Change -36.57% -15.37% -15.37%
Cash & Equivalents $807.6K $1.135M $1.135M
Short-Term Investments
Other Short-Term Assets $32.77K $33.39K $33.39K
YoY Change 146.39% -54.1% -54.1%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.283M $1.334M $1.334M
YoY Change -17.77% -21.92% -21.92%
LONG-TERM ASSETS
Property, Plant & Equipment $13.35M $13.48M $13.48M
YoY Change -2.13% -1.79% -1.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $13.68M $13.82M $13.82M
YoY Change 0.27% 0.67% 0.67%
TOTAL ASSETS
Total Short-Term Assets $1.283M $1.334M $1.334M
Total Long-Term Assets $13.68M $13.82M $13.82M
Total Assets $14.96M $15.15M $15.15M
YoY Change -1.59% -1.83% -1.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $86.78K $102.3K $102.3K
YoY Change -33.16% -47.07% 23.94%
Accrued Expenses $54.49K $52.89K $52.89K
YoY Change -6.05% -18.94% -18.94%
Deferred Revenue
YoY Change
Short-Term Debt $5.082M $5.082M $5.082M
YoY Change 15.85% 3287.77% 3287.77%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.223M $5.243M $5.243M
YoY Change 14.03% 949.62% 949.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $4.201M $4.204M $4.204M
YoY Change -0.3% -0.29% -0.29%
Total Long-Term Liabilities $4.201M $4.204M $4.204M
YoY Change -12.39% -53.98% -53.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.223M $5.243M $5.243M
Total Long-Term Liabilities $4.201M $4.204M $4.204M
Total Liabilities $9.424M $9.448M $9.448M
YoY Change 0.52% -1.95% -1.95%
SHAREHOLDERS EQUITY
Retained Earnings -$20.03M -$19.85M
YoY Change 1.47% 0.48%
Common Stock $2.439K $2.439K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.535M $5.707M $5.707M
YoY Change
Total Liabilities & Shareholders Equity $14.96M $15.15M $15.15M
YoY Change -1.59% -1.83% -1.83%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023
OPERATING ACTIVITIES
Net Income -$172.0K -$148.2K -$94.76K
YoY Change -856.21% -185.76% -45.31%
Depreciation, Depletion And Amortization $115.6K $115.9K $455.9K
YoY Change 2.74% 3.03% 1.33%
Cash From Operating Activities -$337.2K $129.9K $579.9K
YoY Change -403.09% -64.35% -31.68%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$830.00 $279.2K
YoY Change -100.0% -96.43% -213.68%
Acquisitions
YoY Change
Other Investing Activities $9.850K -$386.8K -$356.8K
YoY Change -15.09% -2735.01% -958.57%
Cash From Investing Activities $9.845K -$396.0K -$636.0K
YoY Change -133.85% 4520.54% 211.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 0.000 -$150.0K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -$337.2K 129.9K $579.9K
Cash From Investing Activities $9.845K -396.0K -$636.0K
Cash From Financing Activities $0.00 0.000 -$150.0K
Net Change In Cash -$327.4K -266.1K -$206.1K
YoY Change 382.82% -174.82% -131.97%
FREE CASH FLOW
Cash From Operating Activities -$337.2K $129.9K $579.9K
Capital Expenditures $0.00 -$830.00 $279.2K
Free Cash Flow -$337.2K $130.7K $300.7K
YoY Change -577.75% -66.28% -72.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
62116 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1708507 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6708843 usd
CY2022Q3 us-gaap Assets
Assets
15437530 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
193170 usd
CY2022Q3 acan Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
4303 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
53964 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8612 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11283 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-204013 usd
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
611670 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
482727 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-94755 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
343829 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2017582 usd
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001508348
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Security12g Title
Security12gTitle
Common Stock, ($0.001 Par Value)
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Public Float
EntityPublicFloat
3256000 usd
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24391961
CY2023 dei Auditor Firm
AuditorFirmId
206
CY2023 dei Auditor Name
AuditorName
MaloneBailey, LLP
CY2023 dei Auditor Location
AuditorLocation
Houston, Texas
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1135006 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1341127 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9967 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9967 usd
CY2023Q3 acan Tenant Receivable Current
TenantReceivableCurrent
103450 usd
CY2022Q3 acan Tenant Receivable Current
TenantReceivableCurrent
251462 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23415 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
62766 usd
CY2022Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
43185 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
1333954 usd
CY2023Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
337884 usd
CY2022Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
0 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6778085 usd
CY2023Q3 us-gaap Assets
Assets
15154894 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
87247 usd
CY2023Q3 acan Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
0 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
40686 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6365 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12204 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5243148 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
499529 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
0 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
162353 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4204389 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4216596 usd
CY2023Q3 us-gaap Liabilities
Liabilities
9447537 usd
CY2022Q3 us-gaap Liabilities
Liabilities
9635418 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24391961
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24391961
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24391961
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24391961
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2439 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
2439 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25558362 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25558362 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19853444 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19758689 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5707357 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5802112 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15154894 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15437530 usd
CY2023 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
2552200 usd
CY2022 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
2520555 usd
CY2023 acan Operating Lease Lease Income Related Party
OperatingLeaseLeaseIncomeRelatedParty
0 usd
CY2022 acan Operating Lease Lease Income Related Party
OperatingLeaseLeaseIncomeRelatedParty
407264 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
16170 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
45950 usd
CY2023 us-gaap Gross Profit
GrossProfit
2536030 usd
CY2022 us-gaap Gross Profit
GrossProfit
2881869 usd
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
9743 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
37731 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
359669 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1554948 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
1924360 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
2399142 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-706425 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-655971 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-94755 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-173244 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24333911
CY2021Q3 us-gaap Shares Outstanding
SharesOutstanding
5510410
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
90000 usd
CY2022 acan Warrants Extension
WarrantsExtension
374946 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-173244 usd
CY2022Q3 us-gaap Shares Outstanding
SharesOutstanding
5802112
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-94755 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5707357 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-173244 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
455891 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
449923 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
69242 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
68391 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
374946 usd
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
90000 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
162353 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
107153 usd
CY2023 acan Increase Decrease In Tenant Receivable
IncreaseDecreaseInTenantReceivable
-148012 usd
CY2022 acan Increase Decrease In Tenant Receivable
IncreaseDecreaseInTenantReceivable
-258854 usd
CY2023 acan Increase Decrease In Tenant Receivable Related Party
IncreaseDecreaseInTenantReceivableRelatedParty
-0 usd
CY2022 acan Increase Decrease In Tenant Receivable Related Party
IncreaseDecreaseInTenantReceivableRelatedParty
251462 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-39351 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
49796 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-105923 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3150 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-11286 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-10431 usd
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-2247 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-3516 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
579860 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
848738 usd
CY2023 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
32705 usd
CY2022 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
245577 usd
CY2023 acan Payments To Acquire Property Plant And Equipment Excluding Construction In Progress
PaymentsToAcquirePropertyPlantAndEquipmentExcludingConstructionInProgress
246461 usd
CY2022 acan Payments To Acquire Property Plant And Equipment Excluding Construction In Progress
PaymentsToAcquirePropertyPlantAndEquipmentExcludingConstructionInProgress
-0 usd
CY2023 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
43185 usd
CY2022 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
41564 usd
CY2023 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
400000 usd
CY2022 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
-0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-635981 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
150000 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-150000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-206121 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
644725 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1351094 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
706369 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1144973 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1351094 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
560790 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
563799 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2014Q1 acan Ownership Percentage Transfered
OwnershipPercentageTransfered
0.93 pure
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Use of Estimates</i></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant estimates and assumptions made by management are valuation of equity instruments, deferred tax asset valuation and allowance and collectability of accounts receivable and long-lived assets. Actual results could differ from those estimates as the current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Concentration of Credit Risks and Significant Customers</i></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, notes receivable, deposits tenant receivables and notes receivable. We place our cash with high credit quality financial institutions. As of September 30, 2023 and 2022, we had outstanding notes receivable of $400,000 and $43,185, respectively and tenant receivables of $103,450 and $251,462, respectively, with BASK, Inc. ("BASK").</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">For the year ended September 30, 2023, all of the Company’s revenue was earned from <span style="-sec-ix-hidden:c300">one</span> customer, BASK (which was a related party prior to December 2021, see Note 6).</p>
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8206888 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7960427 usd
CY2023 us-gaap Depreciation
Depreciation
455891 usd
CY2022 us-gaap Depreciation
Depreciation
449923 usd
CY2023Q3 acan Property Lease Unearned Revenue
PropertyLeaseUnearnedRevenue
0 usd
CY2022Q3 acan Property Lease Unearned Revenue
PropertyLeaseUnearnedRevenue
0 usd
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24391961
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24333911
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19853444 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19758689 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-94755 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-173244 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1135006 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1341127 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9967 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9967 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1144973 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1351094 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
11037777 usd
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
11383482 usd
CY2023Q3 acan Deferred Tax Assets Tax Effect Net Operating Loss And Other Temporary Differences
DeferredTaxAssetsTaxEffectNetOperatingLossAndOtherTemporaryDifferences
2539487 usd
CY2022Q3 acan Deferred Tax Assets Tax Effect Net Operating Loss And Other Temporary Differences
DeferredTaxAssetsTaxEffectNetOperatingLossAndOtherTemporaryDifferences
2651840 usd
CY2023Q3 acan Notes And Other Receivables Net
NotesAndOtherReceivablesNet
400000 usd
CY2022Q3 acan Notes And Other Receivables Net
NotesAndOtherReceivablesNet
43185 usd
CY2023Q3 acan Notes And Other Receivables Net Current
NotesAndOtherReceivablesNetCurrent
62116 usd
CY2022Q3 acan Notes And Other Receivables Net Current
NotesAndOtherReceivablesNetCurrent
43185 usd
CY2023Q3 us-gaap Notes Receivable Net
NotesReceivableNet
337884 usd
CY2022Q3 us-gaap Notes Receivable Net
NotesReceivableNet
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-94755 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-173244 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24333911
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2539487 usd
CY2022Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2651840 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2539487 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2651840 usd
CY2023Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q3 acan Deferred Tax Assets Temporary Difference Net Operating Loss
DeferredTaxAssetsTemporaryDifferenceNetOperatingLoss
94755 usd
CY2023Q3 acan Deferred Tax Assets Tax Effect Net Operating Loss
DeferredTaxAssetsTaxEffectNetOperatingLoss
29185 usd
CY2022Q3 acan Deferred Tax Assets Temporary Difference Net Operating Loss
DeferredTaxAssetsTemporaryDifferenceNetOperatingLoss
173244 usd
CY2022Q3 acan Deferred Tax Assets Tax Effect Net Operating Loss
DeferredTaxAssetsTaxEffectNetOperatingLoss
53550 usd
CY2023Q3 acan Deferred Tax Assets Temporary Difference Tax Impact True Up
DeferredTaxAssetsTemporaryDifferenceTaxImpactTrueUp
-0 usd
CY2023Q3 acan Deferred Tax Assets Tax Impact True Up Temporary Difference Tax Effect
DeferredTaxAssetsTaxImpactTrueUpTemporaryDifferenceTaxEffect
-0 usd
CY2022Q3 acan Deferred Tax Assets Temporary Difference Tax Impact True Up
DeferredTaxAssetsTemporaryDifferenceTaxImpactTrueUp
-0 usd
CY2022Q3 acan Deferred Tax Assets Tax Impact True Up Temporary Difference Tax Effect
DeferredTaxAssetsTaxImpactTrueUpTemporaryDifferenceTaxEffect
-0 usd
CY2023Q3 acan Deferred Tax Assets Temporary Difference Other
DeferredTaxAssetsTemporaryDifferenceOther
438313 usd
CY2023Q3 acan Deferred Tax Assets Other Temporary Difference Tax Effect
DeferredTaxAssetsOtherTemporaryDifferenceTaxEffect
135000 usd
CY2022Q3 acan Deferred Tax Assets Temporary Difference Other
DeferredTaxAssetsTemporaryDifferenceOther
721657 usd
CY2022Q3 acan Deferred Tax Assets Other Temporary Difference Tax Effect
DeferredTaxAssetsOtherTemporaryDifferenceTaxEffect
223064 usd
CY2023Q3 acan Deferred Tax Assets Temporary Difference Gross
DeferredTaxAssetsTemporaryDifferenceGross
343558 usd
CY2023Q3 acan Deferred Tax Assets Tax Effect Gross
DeferredTaxAssetsTaxEffectGross
105815 usd
CY2022Q3 acan Deferred Tax Assets Temporary Difference Gross
DeferredTaxAssetsTemporaryDifferenceGross
548413 usd
CY2022Q3 acan Deferred Tax Assets Tax Effect Gross
DeferredTaxAssetsTaxEffectGross
169514 usd
CY2023Q3 acan Deferred Tax Assets Temporary Difference Valuation Allowance
DeferredTaxAssetsTemporaryDifferenceValuationAllowance
343558 usd
CY2023Q3 acan Deferred Tax Assets Tax Effect Valuation Allowance
DeferredTaxAssetsTaxEffectValuationAllowance
105815 usd
CY2022Q3 acan Deferred Tax Assets Temporary Difference Valuation Allowance
DeferredTaxAssetsTemporaryDifferenceValuationAllowance
548413 usd
CY2022Q3 acan Deferred Tax Assets Tax Effect Valuation Allowance
DeferredTaxAssetsTaxEffectValuationAllowance
169514 usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0 usd
CY2023Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023 acan Deferred Tax Assets Valuation Allowance Percent Offset
DeferredTaxAssetsValuationAllowancePercentOffset
1 pure
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-112353 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-92833 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.098 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0991 pure
CY2023 acan Effective Income Tax Rate Reconciliation Federal Statutory And State Combined Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationFederalStatutoryAndStateCombinedIncomeTaxRatePercent
0.308 pure
CY2022 acan Effective Income Tax Rate Reconciliation Federal Statutory And State Combined Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationFederalStatutoryAndStateCombinedIncomeTaxRatePercent
0.3091 pure
CY2023 acan Effective Income Tax Rate Reconciliation Net Operating Loss Percent
EffectiveIncomeTaxRateReconciliationNetOperatingLossPercent
-0.308 pure
CY2022 acan Effective Income Tax Rate Reconciliation Net Operating Loss Percent
EffectiveIncomeTaxRateReconciliationNetOperatingLossPercent
-0.3091 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
195651
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
90000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y8M12D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1700000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.94
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y4M24D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1700000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.94
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y4M24D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y4M24D
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4026650
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.4
CY2022 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P1Y2M12D
CY2023 acan Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
1878650
CY2023 acan Class Of Warrant Or Right Expired During Period Exercise Price
ClassOfWarrantOrRightExpiredDuringPeriodExercisePrice
1.48
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2148000
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.33
CY2023 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P1Y1M17D
CY2022Q3 acan Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
2148000
CY2022Q3 acan Class Of Warrant Or Right Exercisable Exercise Price
ClassOfWarrantOrRightExercisableExercisePrice
1.33
CY2023 acan Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm
P1Y1M17D
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6980957 usd
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4256869 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6708843 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12204 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4204389 usd
CY2023Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P43Y
CY2023Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.079 pure
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
341500 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
341500 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
341500 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
341500 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
341500 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
12977000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14684500 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10467907 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4216593 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12204 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4204389 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
481375 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
475249 usd

Files In Submission

Name View Source Status
0001437749-23-035268-index-headers.html Edgar Link pending
0001437749-23-035268-index.html Edgar Link pending
0001437749-23-035268.txt Edgar Link pending
0001437749-23-035268-xbrl.zip Edgar Link pending
acan-20230930.xsd Edgar Link pending
acan-20230930_cal.xml Edgar Link unprocessable
acan-20230930_def.xml Edgar Link unprocessable
acan20230930_10k.htm Edgar Link pending
ex_608418.htm Edgar Link pending
ex_608419.htm Edgar Link pending
ex_608420.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
acan20230930_10k_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
acan-20230930_pre.xml Edgar Link unprocessable
acan-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable